NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Performance Evaluation of a 3D PSIR Sequence in MRI at 1.5T

CompletedN/A

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild

Conditions: Multiple Sclerosis

Interventions: MRI 1.5 tesla

Countries: France

Inclusion visit (D0): * verification of inclusion and non-inclusion criteria * information and collection of consent * standard imaging protocol prescribed as part of the usual treatment: sagittal T1 and T2 slices after injection of contrast product (Gadolinium), o 3D STIR sequence. * 3D PSIR sequence at the level of the cervical cord for the duration of the additional sequence is 10 minutes, for a total examination time of 45 minutes (instead of 35 minutes).

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Patient over 18 years old
* To benefit from a medullary exploration planned by MRI 1.5T as part of a first evaluation or a re-evaluation of inflammatory involvement of the nevrax
* Express consent to participate in the study
* Affiliate or beneficiary of a social security scheme

Exclusion Criteria:

* Patient benefiting from a legal protection measure
* Pregnant, parturient or breastfeeding woman
* Absolute or relative contraindication to MRI

Locations (6)

Bordeaux, France
Clermont-Ferrand, France
Lille, France
Lyon, France
Paris, France
Paris, France